Patient Understanding of LiverMultiScan

Liver Diseases Clinical Trial

Official title:

Patient Understanding of LiverMultiScan

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02877602
• Other study ID #: Patient LMS
• Status: Completed
• Phase: N/A
• First received: August 17, 2016
• Last updated: January 11, 2018
• Start date: February 2016
• Est. completion date: December 2017

Study information

• Verified date: January 2018
• Source: Perspectum Diagnostics Ltd
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This is a qualitative study to determine which factors affect the patient experience of having a liver MRI, what information patients would like to receive after their MRI, and how patients would like this information communicated to them.

Description:

This is a qualitative study to determine which factors affect the patient experience of having a liver MRI, what information patients would like to receive after their MRI, and how patients would like this information communicated to them. Each individual will receive at least an MRI scan (LiverMultiScan), with many also receiving a FibroScan (Transient Elastography). Patients will then undergo a focused qualitative interview, as well as filling out a questionnaire. The interviews will be thematically analysed and trends identified by significance.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 101
• Est. completion date: December 2017
• Est. primary completion date: December 2017
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 16 Years and older

Eligibility

Inclusion Criteria:

• Individuals with experience of liver disease.

• Individuals over the age of 16.

• Individuals willing to give informed consent for participation in the study.

Exclusion Criteria:

• Individuals with any contraindication to magnetic resonance imaging.

Related Conditions & MeSH terms

• Liver Diseases

Intervention

Device:
• MRI

• Transient Elastography

Locations

Country	Name	City	State
United Kingdom	University of Oxford Centre for Clinical Magnetic Resonance Research (OCMR)	Oxford	Oxfordshire

Sponsors (1)

Lead Sponsor	Collaborator
Perspectum Diagnostics Ltd

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Factors effecting MRI experience and understanding.	This will be analysed based on themes and trends emanating from answers within the focused interview and questionnaire following the scan, and results feedback.	Immediately (within 1 hour) after undergoing the MRI scan, and receiving results feedback.
Secondary	Comparison of MRI to ultrasound scan in terms of patient experience.	This will be analysed based on themes and trends emanating from answers within the focused interview and questionnaire following the scan, and results feedback.	Immediately (within 1 hour) after undergoing an MRI scan, and ultrasound (FibroScan) scan.